Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $2.8 million.

  • Traws Pharma's Non-Current Assets rose 2157692.31% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 459714.29%. This contributed to the annual value of $11000.0 for FY2024, which is 5217.39% down from last year.
  • Traws Pharma's Non-Current Assets amounted to $2.8 million in Q3 2025, which was up 2157692.31% from $252000.0 recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Non-Current Assets peaked at $2.8 million during Q3 2025, and registered a low of $11000.0 during Q4 2024.
  • In the last 5 years, Traws Pharma's Non-Current Assets had a median value of $29000.0 in 2022 and averaged $213210.5.
  • In the last 5 years, Traws Pharma's Non-Current Assets crashed by 7783.78% in 2022 and then soared by 2157692.31% in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's Non-Current Assets stood at $48000.0 in 2021, then crashed by 47.92% to $25000.0 in 2022, then decreased by 8.0% to $23000.0 in 2023, then crashed by 52.17% to $11000.0 in 2024, then surged by 25518.18% to $2.8 million in 2025.
  • Its Non-Current Assets was $2.8 million in Q3 2025, compared to $252000.0 in Q2 2025 and $207000.0 in Q1 2025.